M. Seweryn

The JAK2 V617F point mutation correlates with clinical phenotype in patients with polycythaemia vera and essential thrombocythaemia

G. Helbig, M. Krawczyk, M. Kopera, 2009 .

Testicular cancer developed in a chronic myeloid leukemia patient with a continued complete cytogenetic and molecular response to imatinib. A case report and review of the literature.

S. Kyrcz‐Krzemień, J. Pająk, J. Najda, 2010, Leukemia research.

Infectious complications in patients with acute myeloid leukemia treated according to the protocol with daunorubicin and cytarabine with or without addition of cladribine. A multicenter study by the Polish Adult Leukemia Group (PALG).

W. Jędrzejczak, K. Sułek, T. Robak, 2010, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Safety and Efficacy of Bendamustine Monotherapy in the First-Line Treatment of Patients with Chronic Lymphocytic Leukemia: Polish Lymphoma Research Group Real-Life Analysis

D. Zawirska, A. Malenda, M. Długosz-Danecka, 2019, Chemotherapy.

Treosulfan, cyclophosphamide and antithymocyte globulin for allogeneic hematopoietic cell transplantation in acquired severe aplastic anemia.

M. Markiewicz, J. Hołowiecki, S. Giebel, 2006, Annals of transplantation.

Occurrence of Secondary Malignancies in Chronic Myeloid Leukemia During Therapy with Imatinib Mesylate-Single Institution Experience

A. Tukiendorf, G. Helbig, S. Kyrcz‐Krzemień, 2015, Mediterranean journal of hematology and infectious diseases.

Acute graft-versus-host disease. The incidence and risk factors.

M. Markiewicz, J. Hołowiecki, T. Krużel, 2006, Annals of Transplantation.